150 related articles for article (PubMed ID: 9698999)
1. Pregnancy outcome following maternal organic solvent exposure: a meta-analysis of epidemiologic studies.
McMartin KI; Chu M; Kopecky E; Einarson TR; Koren G
Am J Ind Med; 1998 Sep; 34(3):288-92. PubMed ID: 9698999
[TBL] [Abstract][Full Text] [Related]
2. Paternal organic solvent exposure and adverse pregnancy outcomes: a meta-analysis.
Logman JF; de Vries LE; Hemels ME; Khattak S; Einarson TR
Am J Ind Med; 2005 Jan; 47(1):37-44. PubMed ID: 15597360
[TBL] [Abstract][Full Text] [Related]
3. Risk of spontaneous abortion and maternal exposure to organic solvents in the shoe industry.
Agnesi R; Valentini F; Mastrangelo G
Int Arch Occup Environ Health; 1997; 69(5):311-6. PubMed ID: 9192214
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study.
Khattak S; K-Moghtader G; McMartin K; Barrera M; Kennedy D; Koren G
JAMA; 1999 Mar 24-31; 281(12):1106-9. PubMed ID: 10188661
[TBL] [Abstract][Full Text] [Related]
5. [Occupational exposure to organic solvents and pregnancy. Review of current epidemiologic knowledge].
Saillenfait AM; Robert E
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):374-88. PubMed ID: 11011304
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous abortions and congenital malformations among the wives of men occupationally exposed to organic solvents.
Taskinen H; Anttila A; Lindbohm ML; Sallmén M; Hemminki K
Scand J Work Environ Health; 1989 Oct; 15(5):345-52. PubMed ID: 2799322
[TBL] [Abstract][Full Text] [Related]
7. Exposure to organic solvents and adverse pregnancy outcome.
Windham GC; Shusterman D; Swan SH; Fenster L; Eskenazi B
Am J Ind Med; 1991; 20(2):241-59. PubMed ID: 1951371
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous abortions among women exposed to organic solvents.
Lindbohm ML; Taskinen H; Sallmén M; Hemminki K
Am J Ind Med; 1990; 17(4):449-63. PubMed ID: 2327413
[TBL] [Abstract][Full Text] [Related]
9. Assessment of time to pregnancy and spontaneous abortion status following occupational exposure to organic solvents mixture.
Attarchi MS; Ashouri M; Labbafinejad Y; Mohammadi S
Int Arch Occup Environ Health; 2012 Apr; 85(3):295-303. PubMed ID: 21681482
[TBL] [Abstract][Full Text] [Related]
10. Effects of parental exposure to solvents on pregnancy outcome.
Lindbohm ML
J Occup Environ Med; 1995 Aug; 37(8):908-14. PubMed ID: 8520952
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis.
Kaplan YC; Ozsarfati J; Etwel F; Nickel C; Nulman I; Koren G
Br J Dermatol; 2015 Nov; 173(5):1132-41. PubMed ID: 26215715
[TBL] [Abstract][Full Text] [Related]
12. Medication exposure and spontaneous abortion: a case-control study using a French medical database.
Abadie D; Hurault-Delarue C; Damase-Michel C; Montastruc JL; Lacroix I
Clin Exp Obstet Gynecol; 2015; 42(4):431-6. PubMed ID: 26411206
[TBL] [Abstract][Full Text] [Related]
13. Maternal occupational exposure to solvents and congenital malformations: a prospective study in the general population.
Garlantézec R; Monfort C; Rouget F; Cordier S
Occup Environ Med; 2009 Jul; 66(7):456-63. PubMed ID: 19541806
[TBL] [Abstract][Full Text] [Related]
14. Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes.
Bérard A; Zhao JP; Shui I; Colilla S
Ann Rheum Dis; 2018 Apr; 77(4):500-509. PubMed ID: 29222350
[TBL] [Abstract][Full Text] [Related]
15. Use of antibiotics during pregnancy and risk of spontaneous abortion.
Muanda FT; Sheehy O; Bérard A
CMAJ; 2017 May; 189(17):E625-E633. PubMed ID: 28461374
[TBL] [Abstract][Full Text] [Related]
16. Exposure during pregnancy to glycol ethers and chlorinated solvents and the risk of congenital malformations.
Cordier S; Garlantézec R; Labat L; Rouget F; Monfort C; Bonvallot N; Roig B; Pulkkinen J; Chevrier C; Multigner L
Epidemiology; 2012 Nov; 23(6):806-12. PubMed ID: 23007043
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.
Coppola D; Russo LJ; Kwarta RF; Varughese R; Schmider J
Drug Saf; 2007; 30(3):247-64. PubMed ID: 17343431
[TBL] [Abstract][Full Text] [Related]
18. Combined effect of prenatal solvent exposure and GSTT1 or GSTM1 polymorphisms in the risk of birth defects.
Garlantézec R; Chevrier C; Coiffec I; Celebi C; Cordier S
Birth Defects Res A Clin Mol Teratol; 2012 Jun; 94(6):481-5. PubMed ID: 22570144
[TBL] [Abstract][Full Text] [Related]
19. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death.
Pasternak B; Svanström H; Mølgaard-Nielsen D; Melbye M; Hviid A
JAMA; 2013 Oct; 310(15):1601-11. PubMed ID: 24129464
[TBL] [Abstract][Full Text] [Related]
20. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
Park-Wyllie L; Mazzotta P; Pastuszak A; Moretti ME; Beique L; Hunnisett L; Friesen MH; Jacobson S; Kasapinovic S; Chang D; Diav-Citrin O; Chitayat D; Nulman I; Einarson TR; Koren G
Teratology; 2000 Dec; 62(6):385-92. PubMed ID: 11091360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
